FDA recall D-1139-2023

Product

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Reason for recall

Defective Container: slow leakage under the cap

Distribution

Nationwide in the USA.

Key facts

Status

Terminated

Initiation date

2023-08-23

Report date

2023-09-06

Termination date

2025-08-06

Voluntary/Mandated

Voluntary: Firm initiated

Location

Mississauga, N/A, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1139-2023